Back

Effects of BET Inhibition on lung micro-environmental changes in obesity-related pulmonary Arterial Hypertension (PAH)

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Novel regulators of vascular functions Hypertension, Pulmonary Hypertension ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Marialucia Telesca

Center for Translational and Experimental Cardiology (CTEC), Zurich (Switzerland)

5 More presentations in this session

Presentation thumbnail
Endothelial NRG-1 knock-out causes left ventricle dilation in the presence and absence of angiotensin II administration
Mr B. Van Berlo (Antwerp, BE)
Abstract Slides Video
Presentation thumbnail
Safety, acceptability, and feasibility of acquiring endothelial cells from guidewires in patients having major surgery or with acute critical illness
Mr C. Piercy (Guildford, GB)
Abstract Slides Video
Presentation thumbnail
cAMP/PKA-mediated in vitro angiogenesis: A novel interplay between PKA, RhoA/ROCK, and VEGFR2 signalling
Doctor M. Aslam (Giessen, DE)
Abstract Slides Video
Presentation thumbnail
Coronary microvascular dysfunction in postmenopausal minipigs with multiple risk factors
Doctor O. Sorop (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
Activation, regulation, and effects of the mitochondrial unfolded protein response in endothelial cells
Doctor M. Al Zaidi (Bonn, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Novel regulators of vascular functions

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Employing epi-drugs to rescue lung microenvironmental changes in heart failure with preserved ejection fraction
thumbnail
Congress Presentation
Therapeutic modulation of the lung microenvironment in obesity-induced heart failure with preserved ejection fraction
thumbnail
Congress Presentation
Pathobiological characterization of pulmonary hypertension associated with heart failure with preserved ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources